These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1875666

  • 1. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP, Maev IV, Andreev NG.
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [Abstract] [Full Text] [Related]

  • 2. [The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials].
    Vorob'ev LP, Maev IV.
    Farmakol Toksikol; 1991 Feb; 54(5):54-7. PubMed ID: 1800153
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [New trends in the treatment of hemodynamic disorders in liver cirrhosis].
    Vorob'ev LP, Maev IV.
    Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD.
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [Abstract] [Full Text] [Related]

  • 8. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP, Dubinskiĭ AA, Tereshkin IG.
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [Abstract] [Full Text] [Related]

  • 9. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM, Popescu CR.
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
    Oberti F, Calès P.
    Gastroenterol Clin Biol; 1995 Mar; 19(3):328-31. PubMed ID: 7781957
    [No Abstract] [Full Text] [Related]

  • 14. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM, Balas BI, Diculescu M.
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [Abstract] [Full Text] [Related]

  • 15. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 16. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J, Torres-Zamora M, Gutiérrez-Carreño R, Fierro M, Schaeffer L, Landa L.
    Arch Invest Med (Mex); 1983 May 15; 14(4):331-41. PubMed ID: 6678555
    [No Abstract] [Full Text] [Related]

  • 17. [A comparative evaluation of the hemodynamic effects of nitrosorbide, korinfar, obzidan and spesikor in blockade of the left branch of the bundle of His].
    Maev IV, V'iuchnova ES, Vorob'ev LP.
    Eksp Klin Farmakol; 1993 May 15; 56(1):36-9. PubMed ID: 8324471
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ, Shin MS, Oh KY, Kim MG, Shin KC, Park YM, Kim BR, Chung WJ, Ahn TH, Choi IS, Shin EK.
    Eur J Gastroenterol Hepatol; 2010 Dec 15; 22(12):1503-5. PubMed ID: 21389799
    [Abstract] [Full Text] [Related]

  • 20. Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.
    Heebøll S, Villadsen GE, Aagaard NK, Grønbæk H, Vilstrup H, Keiding S.
    Scand J Gastroenterol; 2013 Aug 15; 48(8):969-73. PubMed ID: 23755897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.